RegulationVitalspan Wire conceptual illustrationThe agency's new product-specific drafts sharpen the scientific path for evaluating complex peptide generics. Here is what changed—and what did not.
Three editions every weekday.
Updated as the evidence changes.
PeptidesVitalspan Wire conceptual illustrationA clinical review separates established teriparatide use from experimental antimicrobial, cartilage-penetrating and AI-designed peptide platforms.
PeptidesVitalspan Wire conceptual illustrationIDR-1002 reduced inflammatory markers, supported mineralization and improved tissue organization in laboratory and rat pulpitis experiments.
PeptidesVitalspan Wire conceptual illustrationThe modular system paired a HER2-targeting engager with localized IL-12, producing stronger immune responses in a model tumor environment.
PeptidesVitalspan Wire conceptual illustrationThe candidate reduced a METTL3-METTL14 interaction signal and cellular m6A levels, but all antitumor evidence remains in vitro.
Conceptual scientific illustration.
Not presented as study evidence.
Every consequential story carries a visible evidence grade, a primary-source trail and a plain-language account of what remains unknown.
Read our standards →Timely enough to matter.
Structured enough to be reliable.
Overnight research, journals and regulatory notices
Study analysis, explainers and claim checks
Breaking developments, context and what comes next
